dc.contributor.author | Pan American Health Organization | |
dc.date.accessioned | 2020-09-21T19:34:34Z | |
dc.date.available | 2020-09-21T19:34:34Z | |
dc.date.issued | 2020-07-08 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/2188 | |
dc.description.abstract | In January 2020, the etiologic agent responsible for a cluster of severe pneumonia cases in Wuhan, China, was identified as being a novel betacoronavirus, distinct from SARS-CoV and MERS-CoV. On 11 February 2020, the International Committee on Taxonomy of Viruses (ICTV) announced that the virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On the same day, WHO named the disease as coronavirus disease COVID-19. For communication purposes, we will refer the virus as “the virus responsible for COVID-19†or “the COVID-19 virus†. Complete genomic sequences of the COVID-19 virus have been released and different molecular detection protocols developed but not fully validated yet. However, given the current circulation of COVID-19 in the Americas region, the Pan American Health Organization/World Health Organization (PAHO/WHO) recommends to Member States to ensure timely identification of suspect cases, collection and shipment of samples to reference laboratories, and implementation of molecular detection protocols, according to the laboratory capacity. | |
dc.language | English | |
dc.subject | Infecctious Diseases | |
dc.subject | COVID-19 | |
dc.subject | Coronavirus | |
dc.title | Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection, 8 July 2020 | |
eihealth.country | Regional, Americas (PAHO/OPS) | |
eihealth.category | Infection prevention and control, including health care workers protection | |
eihealth.type | WHO/PAHO Guidance | |
eihealth.maincategory | Slow Spread / Reducir la Dispersión | |